Behrend E N, Grauer G F, Greco D S, Rose B J, Thrall M A
Department of Clinical Sciences, Colorado State University, Fort Collins 80523, USA.
J Am Anim Hosp Assoc. 1996 Jan-Feb;32(1):11-8. doi: 10.5326/15473317-32-1-11.
Platelet aggregation in response to collagen (1 or 3 micrograms/ml), arachidonic acid (10(-2) M), and adenosine diphosphate (ADP, 2 microM) was compared in healthy cats treated with diltiazem (approximately 2 mg/kg body weight, q 8 hrs for 10 doses), aspirin (approximately 21 mg/kg body weight [1 baby aspirin], q 72 hrs for three doses), or a combination of diltiazem and aspirin. Baseline values obtained prior to treatment served as controls. Addition of arachidonic acid to blood resulted in an impedance change (i.e., aggregation) with time in samples from the nontreated cats and the cats treated with diltiazem, but the addition had no effect in blood from cats treated with aspirin alone or with a combination of diltiazem and aspirin. Platelet aggregation in response to either concentration of collagen or to ADP was not altered by any treatment. Secretion of adenosine triphosphate (ATP) from the platelets was measured when the aggregating agent was 3 micrograms/ml collagen; secretion was not affected by any treatment.
对接受地尔硫䓬(约2mg/kg体重,每8小时一次,共10剂)、阿司匹林(约21mg/kg体重[1片小儿阿司匹林],每72小时一次,共三剂)或地尔硫䓬与阿司匹林联合治疗的健康猫,比较其对胶原蛋白(1或3微克/毫升)、花生四烯酸(10⁻²M)和二磷酸腺苷(ADP,2微摩尔)的血小板聚集情况。治疗前获得的基线值用作对照。向血液中添加花生四烯酸会导致未治疗的猫和接受地尔硫䓬治疗的猫的样本中阻抗随时间变化(即聚集),但添加花生四烯酸对单独接受阿司匹林治疗或接受地尔硫䓬与阿司匹林联合治疗的猫的血液没有影响。对任何一种浓度的胶原蛋白或ADP的血小板聚集不受任何治疗的改变。当聚集剂为3微克/毫升胶原蛋白时,测量血小板中三磷酸腺苷(ATP)的分泌;分泌不受任何治疗的影响。